Chemours Quarterly Income Statement
NYSE: CCIndustrialsMajor ChemicalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Chemours revenue and earnings
In the quarter ended Jun 30, 2026, Chemours generated $1.59 billion in revenue, down 1.5% from the same quarter a year earlier. Chemours reported a net loss of $274.0 million, compared with a loss of $380.0 million a year earlier. Gross margin was 18.0% (up from 17.2%).
Diluted earnings per share came in at -$1.81.
Summary generated from market data by MetaCap's automated system. Methodology
Chemours income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.59B | 1.38B | 1.33B | 1.50B | 1.61B | 1.37B | 1.36B | 1.51B | 1.55B | 1.36B | 1.37B | 1.50B |
| Revenue growth (YoY) | -1.49% | +0.95% | -2.21% | -0.86% | +3.93% | +0.44% | -0.66% | +0.47% | -6.39% | -12.07% | +2.24% | -15.53% |
| Cost of Revenue | 1.30B | 1.17B | 1.17B | 1.26B | 1.34B | 1.13B | 1.09B | 1.22B | 1.25B | 1.08B | 1.11B | 1.23B |
| Gross Profit | 286.00M | 212.00M | 156.00M | 233.00M | 278.00M | 236.00M | 265.00M | 286.00M | 308.00M | 284.00M | 251.00M | 273.00M |
| Operating Expenses | 499.00M | 186.00M | 161.00M | 152.00M | 470.00M | 183.00M | 204.00M | 267.00M | 183.00M | 169.00M | 257.00M | 319.00M |
| Research & Development | 27.00M | 26.00M | 27.00M | 26.00M | 28.00M | 27.00M | 26.00M | 29.00M | 26.00M | 28.00M | 26.00M | 28.00M |
| Selling, General & Admin | 469.00M | 147.00M | 130.00M | 122.00M | 424.00M | 123.00M | 170.00M | 137.00M | 154.00M | 137.00M | 219.00M | 165.00M |
| Interest Expense | 68.00M | 69.00M | 68.00M | 68.00M | 67.00M | 66.00M | 67.00M | 68.00M | 66.00M | 63.00M | 63.00M | 55.00M |
| Other Income (Expense) | 273.00M | 22.00M | 3.00M | 16.00M | 2.00M | 5.00M | -2.00M | 6.00M | -1.00M | 5.00M | -9.00M | 102.00M |
| Pretax Income | -1.00M | -22.00M | -67.00M | 38.00M | -248.00M | 0 | 1.00M | -32.00M | 69.00M | 70.00M | -71.00M | 13.00M |
| Income Tax | 273.00M | 7.00M | -19.00M | -8.00M | 131.00M | 5.00M | 12.00M | 0 | 9.00M | 16.00M | -38.00M | 1.00M |
| Net Income | -274.00M | -29.00M | -47.00M | 46.00M | -380.00M | -5.00M | -11.00M | -32.00M | 60.00M | 54.00M | -18.00M | 12.00M |
| Net Income growth (YoY) | — | — | — | — | -733.33% | -109.26% | — | -366.67% | — | -62.76% | — | -95.00% |
| EPS (Basic) | -1.81 | -0.19 | -0.31 | 0.31 | -2.53 | -0.03 | -0.08 | -0.22 | 0.40 | 0.36 | -0.12 | 0.08 |
| EPS (Diluted) | -1.81 | -0.19 | -0.31 | 0.31 | -2.53 | -0.03 | -0.08 | -0.22 | 0.39 | 0.36 | -0.12 | 0.08 |
| Shares Outstanding (Basic) | 151.23M | 150.77M | — | 150.32M | 150.24M | 149.92M | — | 149.70M | 149.41M | 149.04M | — | 148.62M |
| Shares Outstanding (Diluted) | 151.23M | 150.77M | — | 150.78M | 150.24M | 149.92M | — | 149.70M | 150.12M | 150.05M | — | 150.19M |
| Gross Margin | 17.98% | 15.35% | 11.74% | 15.59% | 17.21% | 17.25% | 19.50% | 18.97% | 19.82% | 20.85% | 18.35% | 18.19% |
| Net Margin | -17.22% | -2.10% | -3.54% | 3.08% | -23.53% | -37.00% | -81.00% | -2.12% | 3.86% | 3.96% | -132.00% | 80.00% |
This table shows 12 quarterly periods of Chemours's income statement, from Q2 2026 back to Q3 2023, across 17 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow CC's reporting calendar. What is a income statement?